West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $1.96 per share which beat the analyst consensus estimate of $1.68 by 16.53 percent. This is a 5.95 percent increase over earnings of $1.85 per share from the same period last year. The company reported quarterly sales of $804.600 million which beat the analyst consensus estimate of $787.929 million by 2.12 percent. This is a 7.73 percent increase over sales of $746.900 million the same period last year.